Conterno Enrique A
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Conterno Enrique A. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| KYNB | Chief Executive Officer | Sale | 1,880 | $2.80 | $5,264 | Jul 7, 2023 |
| KYNB | Chief Executive Officer | Sale | 2,791 | $17.04 | $47,559 | Jun 7, 2023 |
| KYNB | Chief Executive Officer | Sale | 1,869 | $19.52 | $36,483 | Apr 10, 2023 |
| KYNB | Chief Executive Officer | Sale | 19,489 | $20.20 | $393,678 | Mar 10, 2023 |
| KYNB | Chief Executive Officer | Sale | 24,672 | $21.16 | $522,060 | Mar 8, 2023 |
| KYNB | Chief Executive Officer | Award / Grant | 85,300 | — | — | Feb 21, 2023 |
| KYNB | Chief Executive Officer | Sale | 1,538 | $19.95 | $30,683 | Jan 6, 2023 |
| KYNB | Chief Executive Officer | Sale | 2,543 | $15.79 | $40,154 | Dec 8, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,296 | $14.26 | $18,481 | Oct 6, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,772 | $12.26 | $21,725 | Sep 6, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,296 | $12.40 | $16,070 | Jul 6, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,772 | $9.50 | $16,834 | Jun 6, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,311 | $12.73 | $16,689 | Apr 7, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 7,081 | $12.69 | $89,858 | Mar 7, 2022 |
| KYNB | Chief Executive Officer | Award / Grant | 179,400 | — | — | Feb 14, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,536 | $13.93 | $21,396 | Jan 6, 2022 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,859 | $10.20 | $18,962 | Oct 6, 2021 |
| KYNB | Chief Executive Officer | Tax Withholding | 1,859 | $25.06 | $46,587 | Jul 6, 2021 |
| KYNB | Chief Executive Officer | Award / Grant | 82,000 | — | — | Feb 24, 2021 |
| KYNB | Chief Executive Officer | Tax Withholding | 5,411 | $38.31 | $207,295 | Jan 6, 2021 |
| KYNB | Chief Executive Officer | Purchase | 19,800 | $35.28 | $698,544 | Jun 10, 2020 |
| KYNB | Chief Executive Officer | Award / Grant | 60,000 | — | — | Jan 6, 2020 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Sale | 25,000 | $121.00 | $3,025,000 | Feb 15, 2019 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Award / Grant | 26,681 | $120.17 | $3,206,256 | Feb 4, 2019 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Award / Grant | 26,682 | $120.17 | $3,206,376 | Feb 4, 2019 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Option Exercise | 12,222 | — | — | Feb 1, 2019 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Sale | 25,000 | $85.00 | $2,125,000 | May 31, 2018 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Tax Withholding | 8,934 | $81.07 | $724,279 | May 1, 2018 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Tax Withholding | 9,512 | $81.45 | $774,752 | Feb 1, 2018 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Award / Grant | 12,437 | $87.60 | $1,089,481 | Jan 29, 2018 |
| LLY | SVP&Pres, LillyDiab & LillyUSA | Sale | 25,000 | $82.76 | $2,069,000 | May 4, 2017 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Tax Withholding | 4,810 | $77.03 | $370,514 | Feb 1, 2017 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 20,211 | $75.38 | $1,523,505 | Jan 27, 2017 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Option Exercise | 10,360 | — | — | Feb 1, 2016 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 19,953 | $81.96 | $1,635,348 | Jan 26, 2016 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 25,000 | $83.88 | $2,097,000 | Dec 9, 2015 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Option Exercise | 6,928 | $56.18 | $389,215 | Nov 12, 2015 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Option Exercise | 13,990 | — | — | Feb 1, 2015 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 30,037 | $70.97 | $2,131,726 | Jan 28, 2015 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Tax Withholding | 6,046 | $72.21 | $436,582 | Dec 10, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Tax Withholding | 5,474 | $72.21 | $395,278 | Dec 10, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $66.03 | $330,150 | Nov 3, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $64.86 | $324,300 | Oct 1, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $63.60 | $318,000 | Sep 2, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 10,000 | $63.79 | $637,900 | Jul 25, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Option Exercise | 15,674 | — | — | Feb 1, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Award / Grant | 32,248 | $54.23 | $1,748,809 | Jan 28, 2014 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $53.79 | $268,950 | Aug 15, 2013 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $51.43 | $257,150 | Jul 15, 2013 |
| LLY | Sr. VP & Pres., Lilly Diabetes | Sale | 5,000 | $52.45 | $262,250 | Jun 17, 2013 |